Wednesday, December 04, 2019 10:34:21 AM
"All they have to go on is pre-clinical and clinical trial results.
If those are good, expectations for partnering are justified." For the most part public companies are obligated to share their findings with shareholders', honestly. I believe man investor's have become somewhat skeptical based upon r.o.i compared to company proclamations.
"So for an investor to supposedly have thrown a ton of cash into a bio investment, suffer major losses due to buying at the wrong time or buying too early in the life cycle of the clinical trials, then IMO that makes them one hell of a poor investor if they then claim the risk was too great and is still too great far into the trial cycle." I guess some are better at reading the tea leaves than others-https://investorshub.advfn.com/boards/read_msg.aspx?message_id=80937422.
"Brilacidin OM keeps regularly checking off every box that must be stamped prior to approval and until it fails to do so my expectation is for it to succeed. Having done well thru a P2 means that many more times will the drug in trials succeed as opposed to failing as only a P3 is left to pass." Sounds failiar-https://investorshub.advfn.com/boards/read_msg.aspx?message_id=80937422
"Risk still at hand, yes. But risk that many BPs will accept in their quest to land a drug with multi-billion dollar per year potential." Not much risk left, only pennies to loose. Where have you gone Boston Business Journal?
"Like our chances." Never been better?!??
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM